SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4233-4239

  Consiglio, Camila Rosat ^a   Juliana Da Silveira, Schauren ^a   Monticielo, Odirlei André ^b   Xavier, Ricardo Machado ^b   Brenol, João Carlos Tavares ^b   Chies, José Artur Bogo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Immunogenetics; Polymorphism; SIRT1; Systemic lupus erythematosus

Indexed keywords

GENOMIC DNA; SIRTUIN 1; SIRT1 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MODIFIER GENE; MOLECULAR PATHOLOGY; MORBIDITY; PROMOTER REGION; SEQUENCE HOMOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLELE; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX; SIRTUIN 1;

EID: 84903378852     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3294-3     Document Type: Article

References (47)

1. Finkel T, Deng CX, Mostoslavsky R (2009) Recent progress in the biology and physiology of sirtuins. Nature 460(7255): 587-591. doi:10.1038/nature08197
2. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16(1):93-105. doi:10.1016/j.molcel.2004. 08.031 (Pubitemid 39330155)
3. Vaquero A, Sternglanz R, Reinberg D (2007) NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26(37):5505-5520. doi:10.1038/sj.onc.1210617 (Pubitemid 47255931)
4. Yuan J, Pu M, Zhang Z, Lou Z (2009) Histone H3-K56 acetylation is important for genomic stability in mammals. Cell Cycle 8(11):1747-1753. doi:10.4161/cc.8.11.8620
5. Kong S, McBurney MW, Fang D (2012) Sirtuin 1 in immune regulation and autoimmunity. Immunol Cell Biol 90(1):6-13. doi:10.1038/icb.2011.102
6. Zhang R, Chen HZ, Liu JJ, Jia YY, Zhang ZQ, Yang RF, Zhang Y, Xu J, Wei YS, Liu DP, Liang CC, Liang CC (2010) SIRT1 suppresses activator protein-1 transcriptional activity and cyclo-oxygenase-2 expression in macrophages. J Biol Chem 285(10):7097-7110. doi:10.1074/jbc.M109.038604
7. Zhang J, Lee SM, Shannon S, Gao B, Chen W, Chen A, Divekar R, McBurney MW, Braley-Mullen H, Zaghouani H, Fang D (2009) The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 119(10):3048-3058. doi:10.1172/JCI38902
8. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369-2380. doi:10.1038/sj.emboj.7600244 (Pubitemid 38954844)
9. Schug TT, Xu Q, Gao H, Peres-da-Silva A, Draper DW, Fessler MB, Purushotham A, Li X (2010) Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 30(19):4712-4721. doi:10.1128/MCB. 00657-10
10. Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J (2011) Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 6(11):e27081. doi:10.1371/journal.pone.0027081
11. Stein S, Schafer N, Breitenstein A, Besler C, Winnik S, Lohmann C, Heinrich K, Brokopp CE, Handschin C, Landmesser U, Tanner FC, Luscher TF, Matter CM (2010) SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging (Albany NY) 2(6):353-360
12. Gao B, Kong Q, Kemp K, Zhao YS, Fang D (2012) Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance. Proc Natl Acad Sci USA 109(3):899-904. doi:10.1073/pnas.1118462109
13. Sequeira J, Boily G, Bazinet S, Saliba S, He X, Jardine K, Kennedy C, Staines W, Rousseaux C, Mueller R, McBurney MW (2008) Sirt1-null mice develop an autoimmune-like condition. Exp Cell Res 314(16):3069-3074. doi:10.1016/j.yexcr. 2008.07.011
14. Nakashima CA, Galhardo AP, Silva JF, Fiorenzano GR, Santos AB, Leite MF, Nogueira MA, Menolli PV, Menolli RA (2011) Incidence and clinical-laboratory aspects of systemic lupus erythematosus in a Southern Brazilian city. Rev Bras Reumatol 51(3):231-239. doi:10.1590/S0482-50042011000300004
15. Vilar MJ, Sato EI (2002) Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). Lupus 11(8):528-532. doi:10.1191/0961203302lu244xx (Pubitemid 34948072)
16. Yacoub Wasef SZ (2004) Gender differences in systemic lupus erythematosus. Gend Med 1(1):12-17. doi:10.1016/S1550-8579(04)80006-8
17. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK (1995) Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38(9):1260-1270
18. Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W, Zhang G, Zhou Y, Su Y, Lu Q (2008) Abnormal histone modification patterns in lupus CD4+ T cells. J Rheumatol 35(5):804-810 (Pubitemid 351747120)
19. Hu N, Long H, Zhao M, Yin H, Lu Q (2009) Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand J Rheumatol 38(6):464-471. doi:10.3109/03009740902895750
20. Cruz M, Valladares-Salgado A, Garcia-Mena J, Ross K, Edwards M, Angeles-Martinez J, Ortega-Camarillo C, de la Pena JE, Burguete-Garcia AI, Burguete-Garcia AI, Wacher-Rodarte N, Ambriz R, Rivera R, D'Artote AL, Peralta J, Parra EJ, Kumate J (2010) Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. Diabetes Metab Res Rev 26(4):261-270. doi:10.1002/dmrr.1082
21. Clark SJ, Falchi M, Olsson B, Jacobson P, Cauchi S, Balkau B, Marre M, Lantieri O, Andersson JC, Jernas M, Aitman TJ, Richardson S, Sjostrom L, Wong HY, Carlsson LM, Froguel P, Walley AJ (2011) Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity (Silver Spring) 20(1):178-185. doi:10.1038/oby.2011.200
22. Zhang A, Wang H, Qin X, Pang S, Yan B (2012) Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease. Biochem Biophys Res Commun 422(4):693-696. doi:10.1016/j.bbrc. 2012.05.059
23. Rai E, Sharma S, Kaul S, Jain K, Matharoo K, Bhanwer AS, Bamezai RN (2012) The interactive effect of SIRT1 promoter region polymorphism on type 2 diabetes susceptibility in the North Indian population. PLoS One 7(11):e48621. doi:10.1371/journal.pone.0048621
24. Naqvi A, Hoffman TA, DeRicco J, Kumar A, Kim CS, Jung SB, Yamamori T, Kim YR, Mehdi F, Kumar S, Rankinen T, Ravussin E, Irani K (2010) A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Hum Mol Genet 19(21):4123-4133. doi:10.1093/hmg/ddq331
25. Maeda S, Koya D, Araki S, Babazono T, Umezono T, Toyoda M, Kawai K, Imanishi M, Uzu T, Suzuki D, Maegawa H, Kashiwagi A, Iwamoto Y, Nakamura Y (2011) Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes. Clin Exp Nephrol 15(3):381-390. doi:10.1007/s10157-011-0418-0
26. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41(6):703-707. doi:10.1038/ng.381
27. Biason-Lauber A, Boni-Schnetzler M, Hubbard BP, Bouzakri K, Brunner A, Cavelti-Weder C, Keller C, Meyer-Boni M, Meier DT, Brorsson C, Timper K, Leibowitz G, Patrignani A, Bruggmann R, Boily G, Zulewski H, Geier A, Cermak JM, Elliott P, Ellis JL, Westphal C, Knobel U, Eloranta JJ, Kerr-Conte J, Pattou F, Konrad D, Matter CM, Fontana A, Rogler G, Schlapbach R, Regairaz C, Carballido JM, Glaser B, McBurney MW, Pociot F, Sinclair DA, Donath MY (2013) Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 17(3):448-455. doi:10.1016/j.cmet.2013.02.001
28. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241-250. doi:10.1097/01.ASN. 0000108969.21691.5D (Pubitemid 38140764)
29. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy Fde S, Kohlrausch F, Magno LA, Montenegro RC, Moraes MO, de Moraes ME, de Moraes MR, Ojopi EB, Perini JA, Racciopi C, Ribeiro-Dos-Santos AK, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6(2):e17063. doi:10.1371/journal.pone.0017063
30. Santos NP, Ribeiro-Rodrigues EM, Ribeiro-Dos-Santos AK, Pereira R, Gusmao L, Amorim A, Guerreiro JF, Zago MA, Matte C, Hutz MH, Santos SE (2010) Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum Mutat 31(2):184-190. doi:10.1002/humu.21159
31. Zambra FM, Biolchi V, Brum IS, Chies JA (2013) CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer. Hum Immunol 74(8):1003-1008. doi:10.1016/j.humimm.2013.04.031
32. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. doi:10.1093/bioinformatics/bth457 (Pubitemid 40202029)
33. Abramson JH (2004) WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1(1):6. doi:10.1186/1742-5573-1-6
34. Long JC (1999) Multiple locus haplotype analysis, version 3.0. Software and documentation distributed by the author. Department of Human Genetics, University of Michigan Medical School, Ann Arbor
35. Zhang WG, Bai XJ, Chen XM (2010) SIRT1 variants are associated with aging in a healthy Han Chinese population. Clin Chim Acta 411(21-22):1679-1683. doi:10.1016/j.cca.2010.06.030
36. Kuningas M, Putters M, Westendorp RG, Slagboom PE, van Heemst D (2007) SIRT1 gene, age-related diseases, and mortality: the Leiden 85-plus study. J Gerontol A Biol Sci Med Sci 62(9):960-965 (Pubitemid 47531211)
37. Aringer M, Feierl E, Steiner G, Stummvoll GH, Hofler E, Steiner CW, Radda I, Smole JS, Graninger WB (2002) Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death. Lupus 11(2):102-108. doi:10.1191/0961203302lu160oa (Pubitemid 34259440)
38. Habib HM, Taher TE, Isenberg DA, Mageed RA (2009) Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Scand J Rheumatol 38(2):112-120. doi:10.1080/03009740802409496
39. Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM (2013) The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 83(3):404-413. doi:10.1038/ki.2012.394
40. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D (2006) Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med 40(12):2175-2182. doi:10.1016/j. freeradbiomed.2006.02.014 (Pubitemid 43903102)
41. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, Isono M, Uzu T, Guarente L, Kashiwagi A, Koya D (2007) SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 282(1):151-158. doi:10.1074/jbc.M605904200 (Pubitemid 47076643)
42. Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25-33. doi:10.1016/j.jaut.2013.01.008
43. Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, Yamanouchi Y, Kinoshita Y, Kawashima K, Fukuo Y, Naitoh H, Umene-Nakano W, Inada T, Nakamura J, Ozaki N, Iwata N (2010) SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disord 126(1-2):167-173. doi:10.1016/j.jad.2010.04.003
44. Kishi T, Fukuo Y, Okochi T, Kitajima T, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Correll CU, Iwata N (2011) No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population. Hum Psychopharmacol 26(7):445-450. doi:10.1002/hup.1223
45. Kishi T, Fukuo Y, Kitajima T, Okochi T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Ozaki N, Iwata N (2011) SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. Genes Brain Behav 10(3):257-263. doi:10.1111/j.1601-183X.2010.00661.x
46. Flachsbart F, Croucher PJ, Nikolaus S, Hampe J, Cordes C, Schreiber S, Nebel A (2006) Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. Exp Gerontol 41(1):98-102. doi:10.1016/j.exger. 2005.09.008 (Pubitemid 43031374)
47. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, Mc-Carroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747-753. doi:10.1038/nature08494